ESRD as a window into America's cost crisis in health care

Journal of the American Society of Nephrology

Volumn 20, Issue 10, 2009, Pages 2093-2097

  Knauf, Felix ^a   Aronson, Peter S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEMODIALYSIS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEDICARE; PRIORITY JOURNAL; UNITED STATES; CHRONIC KIDNEY FAILURE; COST BENEFIT ANALYSIS; ECONOMICS; GLOMERULUS FILTRATION RATE; HUMAN; QUALITY ADJUSTED LIFE YEAR;

COST-BENEFIT ANALYSIS; GLOMERULAR FILTRATION RATE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY-ADJUSTED LIFE YEARS;

EID: 70349909964     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009070715     Document Type: Article

References (42)

1. Income, Poverty, and Health Insurance Coverage in the United States: 2006. Available at http://www.census.gov/hhes/www/hlthins/hlthin06.html. Accessed August 10, 2009
2. Davis K: Slowing the growth of health care costs-Learning from international experience. N Engl J Med 359: 1751-1755, 2008
3. Public Policy Committee of the American College of Physicians, Ginsburg JA, Doherty RB, Ralston JF Jr, Senkeeto N, Cooke M, Cutler C, Fleming DA, Freeman BP, Gluckman RA, Liebow M, McLean RM, Musana KA, Nichols PM, Purtle MW, Reynolds PP, Weaver KM, Dale DC, Levine JS, Stubbs JW: Achieving a high-performance health care system with universal access: What the United States can learn from other countries. Ann Intern Med 148: 55-75, 2008
4. Fuchs VR: Three "inconvenient truths" about health care. N Engl J Med 359: 1749-1751, 2008
5. Van de Water PN: Medicare finances: Findings of the 2008 Trustees Report. Medicare Brief 18: 1-7, 2008
6. Neilson EG: Baumol's curse on medicine. J Am Soc Nephrol 19: 1049-1053, 2008
7. Chernew ME, Hirth RA, Cutler DM: Increased spending on health care: How much can the United States afford? Health Aff (Millwood) 22: 15-25, 2003
8. Bodenheimer T: High and rising health care costs. Part 1: Seeking an explanation. Ann Intern Med 142: 847-854, 2005 (Pubitemid 40664044)
9. Marmor T, Oberlander J, White J: The Obama administration's options for health care cost control: Hope versus reality. Ann Intern Med 150: 485-489, 2009
10. Dor A, Pauly MV, Eichleay MA, Held PJ: End-stage renal disease and economic incentives: The international study of health care organization and financing (ISHCOF). Int J Health Care Finance Econ 7: 73-111, 2007
11. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol 14: 3270-3277, 2003 (Pubitemid 37509303)
12. Goodkin DA, Young EW, Kurokawa K, Prutz KG, Levin NW: Mortality among hemodialysis patients in Europe, Japan, and the United States: Case-mix effects. Am J Kidney Dis 44: 16-21, 2004 (Pubitemid 39369936)
13. Foley RN, Hakim RM: Why is the mortality of dialysis patients in the United States much higher than the rest of the world? J Am Soc Nephrol 20: 1432-1435, 2009
14. Levinsky NG: The organization of medical care. Lessons from the Medicare end stage renal disease program. N Engl J Med 329: 1395-1399, 1993
15. Committee on Chronic Kidney Disease. Report from the Committee on Chronic Kidney Disease, Washington DC, U.S. Bureau of the Budget, 1967
16. U.S. Renal Data System 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
17. Kurella M, Covinsky KE, Collins AJ, Chertow GM: Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146: 177-183, 2007 (Pubitemid 351650630)
18. Muntner P, Coresh J, Powe NR, Klag MJ: The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 14: 1568-1577, 2003 (Pubitemid 36687058)
19. Hsu CY, Go AS, McCulloch CE, Darbinian J, Iribarren C: Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. Clin J Am Soc Nephrol 2: 81-88, 2007
20. Rosansky SJ, Clark WF, Eggers P, Glassock RJ: Initiation of dialysis at higher GFRs: Is the apparent rising tide of early dialysis harmful or helpful? Kidney Int 2009 [Epub ahead of print]
21. McDonald S, McCredie M, Williams S, Stewart J: Factors influencing reported rates of treated end-stage renal disease. Adv Chronic Kidney Dis 12: 32-38, 2005 (Pubitemid 40255601)
22. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 22: 1955-1962, 2007
23. Smith C, Da Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K: Choosing not to dialyse: Evaluation of planned nondialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract 95: c40-c46, 2003
24. Davison SN, Jhangri GS, Holley JL, Moss AH: Nephrologists' reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol 1: 1256-1262, 2006
25. Himmelfarb J, Berns A, Szczech L, Wesson D: Cost, quality, and value: The changing political economy of dialysis care. J Am Soc Nephrol 18: 2021-2027, 2007 (Pubitemid 47041066)
26. Hall YN, Rodriguez RA, Boyko EJ, Chertow GM, O'Hare AM: Characteristics of uninsured Americans with chronic kidney disease. J Gen Intern Med 2009
27. Rettig RA, Norris K, Nissenson AR: Chronic kidney disease in the United States: A public policy imperative. Clin J Am Soc Nephrol 3: 1902-1910, 2008
28. O'Connor KJ, Delmonico FL: Increasing the supply of kidneys for transplantation. Semin Dial 18: 460-462, 2005
29. Abouna GM: Organ shortage crisis: Problems and possible solutions. Transplant Proc 40: 34-38, 2008 (Pubitemid 351186663)
30. Matas AJ, Hippen B, Satel S: In defense of a regulated system of compensation for living donation. Curr Opin Organ Transplant 13: 379-385, 2008
31. Yen EF, Hardinger K, Brennan DC, Woodward RS, Desai NM, Crippin JS, Gage BF, Schnitzler MA: Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 4: 1703-1708, 2004 (Pubitemid 39312307)
32. De Vecchi AF, Dratwa M, Wiedemann ME: Healthcare systems and end-stage renal disease (ESRD) therapies - an international review: Costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 14[Suppl 6]: 31-41, 1999 (Pubitemid 29462212)
33. Rodrigues A: Cost benefits of peritoneal dialysis in specific groups of patients. Contrib Nephrol 163: 285-291, 2009
34. Mehrotra R, Khawar O, Duong U, Fried L, Norris K, Nissenson A, Kalantar-Zadeh K: Ownership patterns of dialysis units and peritoneal dialysis in the United States: Utilization and outcomes. Am J Kidney Dis 54: 289-298, 2009
35. Howard K, Salkeld G, White S, McDonald S, Chadban S, Craig JC, Cass A: The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) 14: 123-132, 2009
36. Korevaar JC, Jansen MA, Dekker FW, Jager KJ, Boeschoten EW, Krediet RT, Bossuyt PM, Netherlands Cooperative Study on the Adequacy of Dialysis Study Group: When to initiate dialysis: Effect of proposed US guidelines on survival. Lancet 358: 1046-1050, 2001
37. Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG: Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 13: 2125-2132, 2002 (Pubitemid 34790790)
38. Galla JH: Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. The Renal Physicians Association and the American Society of Nephrology. J AmSoc Nephrol 11: 1340-1342, 2000
39. Steinbrook R: Saying no isn't NICE - The travails of Britain's National Institute for Health and Clinical Excellence. N Engl J Med 359: 1977-1981, 2008
40. Moss AH, Renal Physicians Association, American Society of Nephrology Working Group: A new clinical practice guideline on initiation and withdrawal of dialysis that makes explicit the role of palliative medicine. J Palliat Med 3: 253-260, 2000
41. Holley JL, Davison SN, Moss AH: Nephrologists' changing practices in reported end-of-life decision-making. Clin J Am Soc Nephrol 2: 107-111, 2007
42. Holley JL, Carmody SS, Moss AH, Sullivan AM, Cohen LM, Block SD, Arnold RM: The need for end-of-life care training in nephrology: National survey results of nephrology fellows. Am J Kidney Dis 42: 813-820, 2003